Key Takeaway
Phoenix announced the last call for its Neuronic photobiomodulation study (64 APOE4 carriers enrolled, $645 device subsidy still available), the upcoming Supplements Module in the Phoenix app with community efficacy and side effect ratings, and the final days for $499 lifetime Founding Member access before moving to annual pricing.
Definition
A validated online cognitive assessment platform used to measure memory, attention, processing speed, and executive function.
Phoenix uses CogniFit to capture baseline and week-12 cognition for Neuronic study participants, providing objective data on photobiomodulation outcomes.
Definition
A Phoenix Community tier offering lifetime access for a one-time payment of $499 before the platform moved to annual pricing.
Founding Members get permanent access to all modules, research partnerships, and the Phoenix app without ongoing subscription fees.
Evidence-Based Content
Reviewed by Dr. Kevin Tran, PharmD · Based on peer-reviewed research · Updated
Key Takeaway
Breakthrough photobiomodulation study offers APOE4 carriers a limited chance to enhance brain health with red light therapy technology at unprecedented subsidized rates.
Dr. Kevin Tran
PharmDDr. Kevin Tran is a Doctor of Pharmacy and APOE4/4 carrier dedicated to helping others with the APOE4 gene variant take proactive steps for their health. He founded The Phoenix Community to provide evidence-based resources and support for APOE4 carriers.
View all articles
